iMD Companies, Inc. (ICBU)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Aug 26, 2025, 2:12 PM EDT
iMD Companies Market Cap
iMD Companies has a market cap or net worth of $2.36 million as of August 26, 2025. Its market cap has decreased by -36.06% in one year.
Market Cap
2.36M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 15, 2008, iMD Companies's market cap has decreased from 99.51M to 2.36M, a decrease of -97.63%. That is a compound annual growth rate of -19.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 2.36M | -75.73% |
| Dec 31, 2024 | 9.74M | 506.15% |
| Dec 29, 2023 | 1.61M | -18.58% |
| Dec 30, 2022 | 1.97M | -73.55% |
| Dec 31, 2021 | 7.46M | 235.46% |
| Dec 31, 2020 | 2.22M | 135.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |